13F-HR: CVS Health Corp's Q3 2024 13F Filing Reveals $230 Million in Holdings

CVS Health Corp's latest 13F filing discloses approximately $230 million in managed securities as of September 30, 2024.

Summary

• CVS Health Corp filed its Form 13F for the quarter ended September 30, 2024.
• The filing reports total holdings valued at $230,201,649.
• The filing includes 5 holdings.
• The largest holding is in SPDR S&P 500 ETF Trust, valued at $165,180,340.
• Other significant holdings include Vanguard Whitehall Fds, and iShares Core High Dividend ETF.
• All holdings are reported with sole voting authority.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Positives

• The filing provides transparency into CVS Health Corp's investment portfolio.
• The portfolio is diversified across multiple securities.

Industry Context

Institutional investment managers are required to file Form 13F to disclose their equity holdings, providing insights into their investment strategies and market trends.

Comparison to Industry Standards

• Form 13F filings are a standard practice for institutional investment managers with over $100 million in assets under management, as mandated by the SEC.
• The composition of CVS Health Corp's portfolio can be compared to those of other large corporations or investment firms to assess its investment strategy and risk profile.
• Benchmarking against industry peers involves analyzing the allocation of assets across different sectors and investment vehicles, such as ETFs and individual stocks.

Stakeholder Impact

• Shareholders can use this information to understand the investment strategy of CVS Health Corp.
• The filing provides insights into the company's asset allocation and risk management practices.

Key Dates